The name of this company, eXIthera, refers to its therapeutic aim, inhibiting Factor XIa, a new target that may offer a way to avoid the bleeding problems with current anticoagulants. Its lead drug, an injectable coded EP-7041, has completed a Phase 1 clinical trial in healthy human subjects and moved to a program in cardiac […]

Detecting cancer early is the key to defeating it. Laboratory for Advanced Medicine (LAM) is working to detect cancer in its infancy when treatment options have the best chance to be successful. The company’s platform technology, IvyGene, detects the presence of cancer in blood samples and gives quantifiable data about the disease. LAM’s approach differs […]

Last week, regulators in the U.S. and Europe disclosed that the same carcinogen that led to numerous recalls over the past year of valsartan and similar blood pressure pills was found in Zantac and other antacid medicines known as ranitidines. The Food and Drug Administration, however, was first alerted to the presence of the carcinogen, […]